Author:
Friedrich Wilhelm,Schwarz Klaus
Reference115 articles.
1. Antoine C, Muller S, Cant A, Cavazzana-Calvo M, Veys P, Vössen J, Fasth A et al; European Group for Blood and Marrow Transplantation; European Society for Immunodeficiency (2003) Long term survival and hematopoietic stem-cell transplantation for immunodeficiencies: report of the European experience 1968–99. Lancet 361:553–560
2. Arredondo-Vega FX, Santsteban I, Richard E, Bali P, Koleilat M, Loubser M, Al-Ghonaium A et al (2002) Adenosine deaminase deficiency with mosaicism for a “second-site suppressor” of a splicing mutation: decline in revertant T lymphocytes during enzyme replacement therapy. Blood 99:1005–1013
3. Arveiler B, de Saint-Basile G, Fischer A, Griscelli C, Mandel JL (1990) Germ-line mosaicism simulates genetic heterogeneity in Wiskott-Aldrich syndrome. Am J Hum Genet 46:906–911
4. Aspenstroem P, Lindberg U, Hall A (1996) Two GTPases, Cdc42 and Rac, bind directly to a protein implicated in the immunodeficiency disorder Wiskott-Aldrich syndrome. Curr Biol 6:70–75
5. Benkerrou M, Gougeon ML, Griscelli C, Fischer A (1990) Hypogammaglobulinémie G et A avec hypergammaglobulinémie M. A propos de 12 observations. Arch Fr Pediatr 47:345–349